Mckesson (MCK) Shares Outstanding (Weighted Average) (2009 - 2026)
Mckesson (MCK) reported Shares Outstanding (Weighted Average) of $123.6 million for Q1 2026, down 2.98% year-over-year from $127.4 million in Q1 2025, and little changed quarter-over-quarter from $123.2 million in Q4 2025.
Mckesson (MCK) Shares Outstanding (Weighted Average) (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 15 years of Shares Outstanding (Weighted Average) data on file, last reported at $123.6 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $123.6 million, down 2.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $123.6 million (down 2.98% YoY), and the FY2026 annual result was $123.6 million, down 2.98% from the prior year.
- Shares Outstanding (Weighted Average) steadied at $123.6 million in Q1 2026 per MCK's latest filing, from $123.2 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $152.3 million in Q1 2022 and troughed at $123.2 million in Q4 2025.
- A 5-year average of $132.5 million and a median of $129.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) retreated 7.68% in 2022, then decreased 2.98% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $143.7 million in 2022, then fell by 6.75% to $134.0 million in 2023, then retreated by 4.33% to $128.2 million in 2024, then slipped by 3.9% to $123.2 million in 2025, then gained by 0.32% to $123.6 million in 2026.
- Business Quant data shows MCK's Shares Outstanding (Weighted Average) at $123.6 million in Q1 2026, $123.2 million in Q4 2025, and $124.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1,767,296.88 Bn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 123.60 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 194.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 235.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 114.94 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 76.43 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.60 Mn |
| Dec 31, 2025 | 123.20 Mn |
| Sep 30, 2025 | 124.50 Mn |
| Jun 30, 2025 | 124.90 Mn |
| Mar 31, 2025 | 127.40 Mn |
| Dec 31, 2024 | 128.20 Mn |
| Sep 30, 2024 | 129.30 Mn |
| Jun 30, 2024 | 129.80 Mn |
| Mar 31, 2024 | 133.20 Mn |
| Dec 31, 2023 | 134.00 Mn |
| Sep 30, 2023 | 134.10 Mn |
| Jun 30, 2023 | 135.50 Mn |
| Sep 30, 2022 | 143.70 Mn |
| Jun 30, 2022 | 144.20 Mn |
| Mar 31, 2022 | 152.30 Mn |
| Jun 30, 2021 | 156.20 Mn |
| Mar 31, 2021 | 160.60 Mn |
| Mar 31, 2020 | 180.60 Mn |
| Sep 30, 2016 | 226.00 Mn |
| Jun 30, 2016 | 225.00 Mn |